T

Tianjin Ringpu Bio-Technology Co Ltd
SZSE:300119

Watchlist Manager
Tianjin Ringpu Bio-Technology Co Ltd
SZSE:300119
Watchlist
Price: 18.4 CNY -4.66% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Tianjin Ringpu Bio-Technology Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Tianjin Ringpu Bio-Technology Co Ltd

Wall Street analysts forecast Tianjin Ringpu Bio-Technology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tianjin Ringpu Bio-Technology Co Ltd is 20.42 CNY with a low forecast of 17.68 CNY and a high forecast of 22.64 CNY.

Lowest
Price Target
17.68 CNY
4% Downside
Average
Price Target
20.42 CNY
11% Upside
Highest
Price Target
22.64 CNY
23% Upside
Tianjin Ringpu Bio-Technology Co Ltd Competitors:
Price Targets
OGI
OrganiGram Holdings Inc
76% Upside
4506
Sumitomo Pharma Co Ltd
10% Downside
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
24% Upside
AMPH
Amphastar Pharmaceuticals Inc
32% Upside
OFSA3
Ouro Fino Saude Animal Participacoes SA
5% Downside
4503
Astellas Pharma Inc
27% Upside
4565
Sosei Group Corp
90% Upside
000423
Dong-E-E-Jiao Co Ltd
35% Upside

Revenue
Forecast

Revenue Estimate
Tianjin Ringpu Bio-Technology Co Ltd

For the last 8 years the compound annual growth rate for Tianjin Ringpu Bio-Technology Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 19%.

14%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Tianjin Ringpu Bio-Technology Co Ltd

For the last 8 years the compound annual growth rate for Tianjin Ringpu Bio-Technology Co Ltd's operating income is 16%. The projected CAGR for the next 3 years is 24%.

16%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Net Income
Forecast

Net Income Estimate
Tianjin Ringpu Bio-Technology Co Ltd

For the last 8 years the compound annual growth rate for Tianjin Ringpu Bio-Technology Co Ltd's net income is 19%. The projected CAGR for the next 3 years is 14%.

19%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-15%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Tianjin Ringpu Bio-Technology Co Ltd's stock price target?
Price Target
20.42 CNY

According to Wall Street analysts, the average 1-year price target for Tianjin Ringpu Bio-Technology Co Ltd is 20.42 CNY with a low forecast of 17.68 CNY and a high forecast of 22.64 CNY.

What is Tianjin Ringpu Bio-Technology Co Ltd's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Tianjin Ringpu Bio-Technology Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 19%.

What is Tianjin Ringpu Bio-Technology Co Ltd's Operating Income forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for Tianjin Ringpu Bio-Technology Co Ltd's operating income is 16%. The projected CAGR for the next 3 years is 24%.

What is Tianjin Ringpu Bio-Technology Co Ltd's Net Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Tianjin Ringpu Bio-Technology Co Ltd's net income is 19%. The projected CAGR for the next 3 years is 14%.

Back to Top